Diabetes drug Actos may raise bladder cancer risk

Since studies of the diabetes drug Actos suggest an increased risk of bladder cancer for patients taking it for more than a year, Health Canada is reviewing the drug.

An FDA analysis half way through a 10-year study showed there was no overall increased risk of bladder cancer with pioglitazone use. But there was in patients with the longest exposure to pioglitazone, and in those exposed to the highest cumulative dose of the drug. Read more…

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: